Growing interest in non-animal respiratory allergy testing – GARD®air data presented by industry leaders
SenzaGen carries out a directed issue of approximately SEK 17.5 million to the institutional investor Eiffel Investment Group
SenzaGen further strengthens US market position with 1.5 MSEK order from global chemical industry leader
